Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment
This study has been terminated.
( The total number of patients has been reached. )
Study NCT00642135 Information provided by Assistance Publique - Hôpitaux de Paris
First Received: March 17, 2008 Last Updated: April 9, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinal Anomalies
Premature Birth
More general conditions related to this trial
Obstetric Labor Complications
Obstetric Labor, Premature
Pregnancy Complications
Interventions listed in this trial
Mydriasert®
Additional drug interventions recognized in this trial
Oxymetazoline
Phenylephrine
Tetrahydrozoline
Tropicamide
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Mydriatics
Nasal Decongestants
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Assistance Publique - Hôpitaux de Paris
Ioltech
Back to top of Main Content